Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SIDT2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | CABP4 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CFAP45 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | BICD1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | CORO1C | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | CREBZF | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | MAGED4B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | CYSLTR1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | CCSAP | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | PDE5A | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |